Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord

Experimental Neurology

Volumn 277, Issue , 2016, Pages 190-201

  Hu, Jian Guo ^a   Shi, Ling Ling ^a   Chen, Yue Juan ^a   Xie, Xiu Mei ^a   Zhang, Nan ^a   Zhu, An You ^a   Jiang, Zheng Song ^a   Feng, Yi Fan ^a   Zhang, Chen ^a   Xi, Jin ^a   Lü, He Zuo ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Immune microenvironment; Locomotor recovery; Myelin basic protein; Passive immunization; Spinal cord injury

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LYMPHOTOXIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; 4-O-METHYL-12-O-TETRADECANOYLPHORBOL 13-ACETATE; CYTOKINE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; LYMPHOCYTE TRANSFER; MACROPHAGE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TISSUE REPAIR; TREATMENT RESPONSE; ADOPTIVE TRANSFER; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; COMPLICATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; METABOLISM; MOTOR ACTIVITY; MOTOR DISORDERS; PATHOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SPRAGUE DAWLEY RAT;

ADOPTIVE TRANSFER; ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MACROPHAGES; MOTOR ACTIVITY; MOTOR DISORDERS; MYELIN BASIC PROTEIN; NITRIC OXIDE SYNTHASE TYPE II; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD INJURIES; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS; TH2 CELLS;

EID: 84960371162     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2016.01.002     Document Type: Article

References (48)

1. Ankeny D.P., Popovich P.G. Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury. Eur. J. Neurosci. 2007, 25:2053-2064.
2. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422-1438.
3. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
4. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., Holford T.R., Hsu C.Y., Noble L.J., Nockels R., Perot P.L., Salzman S.K., Young W. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 1996, 13:343-359.
5. Bethea J.R. Spinal cord injury-induced inflammation: a dual-edged sword. Prog. Brain Res. 2000, 128:33-42.
6. Cao Q., Zhang Y.P., Iannotti C., DeVries W.H., Xu X.M., Shields C.B., Whittemore S.R. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 2005, 191(Suppl. 1):S3-S16.
7. Chen Y.J., Zhu H., Zhang N., Shen L., Wang R., Zhou J.S., Hu J.G., Lu H.Z. Temporal kinetics of macrophage polarization in the injured rat spinal cord. J. Neurosci. Res. 2015, 93:1526-1533.
8. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
9. Guerrero A.R., Uchida K., Nakajima H., Watanabe S., Nakamura M., Johnson W.E., Baba H. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J. Neuroinflammation 2012, 9:40.
10. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 2000, 20:6421-6430.
11. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15173-15178.
12. Hendrix S., Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 2007, 184:100-112.
13. Hu J.G., Shen L., Wang R., Wang Q.Y., Zhang C., Xi J., Ma S.F., Zhou J.S., Lu H.Z. Effects of Olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injury. Neurotherapeutics 2012, 9:422-445.
14. Ibarra A., Garcia E., Flores N., Martinon S., Reyes R., Campos M.G., Maciel M., Mestre H. Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury. Neurosci. Lett. 2010, 476:62-65.
15. Ishii H., Jin X., Ueno M., Tanabe S., Kubo T., Serada S., Naka T., Yamashita T. Adoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury. Cell Death Dis. 2012, 3:e363.
16. Jones T.B., Ankeny D.P., Guan Z., McGaughy V., Fisher L.C., Basso D.M., Popovich P.G. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 2004, 24:3752-3761.
17. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
18. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 2001, 21:4564-4571.
19. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15620-15625.
20. Kipnis J., Mizrahi T., Yoles E., Ben-Nun A., Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 2002, 130:78-85.
21. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 1997, 186:307-312.
22. Lu H.Z., Xu L., Zou J., Wang Y.X., Ma Z.W., Xu X.M., Lu P.H. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury. Brain Behav. Immun. 2008, 22:1217-1230.
23. Ma S.F., Chen Y.J., Zhang J.X., Shen L., Wang R., Zhou J.S., Hu J.G., Lu H.Z. Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury. Brain Behav. Immun. 2015, 45:157-170.
24. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
25. Metz G.A., Merkler D., Dietz V., Schwab M.E., Fouad K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 2000, 883:165-177.
26. Michel R.P., Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 1988, 150:117-136.
27. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
28. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
29. Nakamura M., Houghtling R.A., MacArthur L., Bayer B.M., Bregman B.S. Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp. Neurol. 2003, 184:313-325.
30. Nakamura M., Okada S., Toyama Y., Okano H. Role of IL-6 in spinal cord injury in a mouse model. Clin. Rev. Allergy Immunol. 2005, 28:197-204.
31. Nguyen-Chi M., Laplace-Builhe B., Travnickova J., Luz-Crawford P., Tejedor G., Phan Q.T., Duroux-Richard I., Levraud J.P., Kissa K., Lutfalla G., Jorgensen C., Djouad F. Identification of polarized macrophage subsets in zebrafish. eLife 2015, 4:e07288.
32. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175:4103-4111.
33. Oorschot D.E. Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 1994, 44:233-247.
34. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
35. Plemel J.R., Wee Yong V., Stirling D.P. Immune modulatory therapies for spinal cord injury - past, present and future. Exp. Neurol. 2014, 258C:91-104.
36. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142:258-275.
37. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 2000, 85:9-18. (quiz 18, 21).
38. Schroeter M., Jander S. T-cell cytokines in injury-induced neural damage and repair. Neruomol. Med. 2005, 7:183-195.
39. Schwartz M. Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog. Neurobiol. 2001, 65:489-496.
40. Schwartz M., Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J. Neurol. Sci. 2005, 233:163-166.
41. Stoll G., Jander S., Schroeter M. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J. Neural Transm. Suppl. 2000, 59:81-89.
42. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
43. Teng Y.D., Mocchetti I., Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci. 1998, 10:798-802.
44. Thawer S.G., Mawhinney L., Chadwick K., de Chickera S.N., Weaver L.C., Brown A., Dekaban G.A. Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the lys-EGFP-ki mouse model. J. Neuroimmunol. 2013, 261:7-20.
45. Wu K.L., Chan S.H., Chao Y.M., Chan J.Y. Expression of pro-inflammatory cytokine and caspase genes promotes neuronal apoptosis in Pontine reticular formation after spinal cord transection. Neurobiol. Dis. 2003, 14:19-31.
46. Yang L., Jones N.R., Blumbergs P.C., Van Den Heuvel C., Moore E.J., Manavis J., Sarvestani G.T., Ghabriel M.N. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 2005, 12:276-284.
47. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 2001, 21:3740-3748.
48. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.